Evidence map›Paper›PMID 40297450›Full record

ArticlemedRxiv : the preprint server for health sciences2025

AutoRADP: An Interpretable Deep Learning Framework to Predict Rapid Progression for Alzheimer's Disease and Related Dementias Using Electronic Health Records.

Qiang Yang, Weimin Meng, Pei Zhuang, Stephen Anton, Yonghui Wu, Rui Yin

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiang YangDepartment of Health Outcomes and Biomedical Informatics, University of Florida.
Weimin MengDepartment of Health Outcomes and Biomedical Informatics, University of Florida.
Pei ZhuangDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School.
Stephen AntonDepartment of Physiology and Aging, University of Florida.
Yonghui WuDepartment of Health Outcomes and Biomedical Informatics, University of Florida.
Rui YinDepartment of Health Outcomes and Biomedical Informatics, University of Florida.

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
15/24- Healthy Brain and Child Development National ConsortiumU01DA055358 · NIDA · UNIVERSITY OF FLORIDA · PI GURKA, KELLY K., SCOTT, LISA S. · 2021 to 2023
$3.7M
NCATS NIH HHS UL1 TR000064NCATS NIH HHS UL1 TR001427NIDA NIH HHS U01 DA055358
6 · The paper itself

Abstract

Alzheimer's disease (AD) and AD-related dementias (ADRD) exhibit heterogeneous progression rates, with rapid progression (RP) posing significant challenges for timely intervention and treatment. The increasingly available patient-centered electronic health records (EHRs) have made it possible to develop advanced machine learning models for risk prediction of disease progression by leveraging comprehensive clinical, demographic, and laboratory data. In this study, we propose AutoRADP, an interpretable autoencoder-based framework that predicts rapid AD/ADRD progression using both structured and unstructured EHR data from UFHealth. AutoRADP incorporates a rule-based natural language processing method to extract critical cognitive assessments from clinical notes, combined with feature selection techniques to identify essential structured EHR features. To address the data imbalance issue, we implement a hybrid sampling strategy that combines similarity-based and clustering-based upsampling. Additionally, by utilizing SHapley Additive exPlanations (SHAP) values, we provide interpretable predictions, shedding light on the key factors driving the rapid progression of AD/ADRD. We demonstrate that AutoRADP outperforms existing methods, highlighting the potential of our framework to advance precision medicine by enabling accurate and interpretable predictions of rapid AD/ADRD progression, and thereby supporting improved clinical decision-making and personalized interventions.

Identifiers

PMID40297450
PMCPMC12036374

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.